IL160810A0 - 1-glyoxlylamide indolizines for treating cancer - Google Patents

1-glyoxlylamide indolizines for treating cancer

Info

Publication number: IL160810A0
Authority: IL; Israel
Prior art keywords: substituted; group; unsubstituted; independently; aryl group
Prior art date: 2001-09-13

Application number

IL16081002A

Other languages

English (en)

Original Assignee

Synta Pharmaceuticals Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-13

Filing date

2002-09-13

Publication date

2004-08-31

2002-09-13 Application filed by Synta Pharmaceuticals Corp filed Critical Synta Pharmaceuticals Corp

2004-08-31 Publication of IL160810A0 publication Critical patent/IL160810A0/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

IL16081002A 2001-09-13 2002-09-13 1-glyoxlylamide indolizines for treating cancer IL160810A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US32202001P	2001-09-13	2001-09-13
PCT/US2002/029154 WO2003022846A1 (en)	2001-09-13	2002-09-13	1-glyoxlylamide indolizines for treating cancer

Publications (1)

Publication Number	Publication Date
IL160810A0 true IL160810A0 (en)	2004-08-31

Family

ID=23253054

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL16081002A IL160810A0 (en)	2001-09-13	2002-09-13	1-glyoxlylamide indolizines for treating cancer

Country Status (20)

Country	Link
US (2)	US6861436B2 (xx)
EP (1)	EP1432709B8 (xx)
JP (1)	JP2005504795A (xx)
KR (1)	KR20040053125A (xx)
CN (1)	CN1568324A (xx)
AT (1)	ATE300542T1 (xx)
AU (1)	AU2002333626B2 (xx)
BR (1)	BR0212794A (xx)
CA (1)	CA2459886A1 (xx)
DE (1)	DE60205265T2 (xx)
ES (1)	ES2245747T3 (xx)
HK (1)	HK1063322A1 (xx)
IL (1)	IL160810A0 (xx)
IS (1)	IS7176A (xx)
MX (1)	MXPA04002323A (xx)
NO (1)	NO20041035L (xx)
NZ (1)	NZ531700A (xx)
PT (1)	PT1432709E (xx)
WO (1)	WO2003022846A1 (xx)
ZA (1)	ZA200401996B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040116462A1 (en) *	2002-12-12	2004-06-17	Mitsunori Ono	Indolizine compounds
DE60205265T2 (de) *	2001-09-13	2006-03-30	Synta Pharmaceuticals Corporation, Lexington	1-glyoxylamidindolizine zur behandlung von krebs
EP1537105A2 (en) *	2002-09-13	2005-06-08	Synta Pharmaceuticals Corporation	Synthesis of indolizines
DE10318611A1 (de)	2003-04-24	2004-11-11	Elbion Ag	4-, 6- oder 7-Hydroxyindole mit N-Oxidgruppen und deren Verwendung als Therapeutika
WO2005099824A1 (en) *	2004-03-30	2005-10-27	Synta Pharmaceuticals, Corp.	1-glyoxylamide indolizines for treating lung and ovarian cancer
GB0413605D0 (en)	2004-06-17	2004-07-21	Addex Pharmaceuticals Sa	Novel compounds
WO2006073938A2 (en) *	2004-12-30	2006-07-13	East Carolina University	Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds
BRPI0609802A2 (pt) *	2005-05-20	2017-05-02	Alantos Pharmaceuticals Holding Inc	composto, composição farmacêutica e uso de um composto
US20070155738A1 (en) *	2005-05-20	2007-07-05	Alantos Pharmaceuticals, Inc.	Heterobicyclic metalloprotease inhibitors
EP2320906B1 (en) *	2008-08-14	2016-02-24	Beta Pharma Canada Inc.	Heterocyclic amide derivatives as ep4 receptor antagonists
RU2624506C2 (ru)	2009-04-29	2017-07-04	АМАРИН КОРПОРЕЙШН ПиЭлСи	Фармацевтические композиции, содержащие ера и сердечно-сосудистое средство, и способы их применения
AR077428A1 (es) *	2009-07-29	2011-08-24	Sanofi Aventis	(aza) indolizinacarboxamidas ciclicas su preparacion y su uso como agentes farmaceuticos
CN113603694B (zh) *	2021-07-16	2022-07-22	浙江工业大学	一种1,2-二酮类化合物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2287706A (en) *	1994-03-21	1995-09-27	Fujisawa Pharmaceutical Co	Indolizine derivatives
FR2757166B1 (fr) *	1996-12-12	1999-01-29	Rhone Poulenc Rorer Sa	Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent
WO1998047507A1 (en) *	1997-04-24	1998-10-29	Shionogi & Co., Ltd.	Method for the treatment of stroke using n-heterocyclic glyoxylamide compounds
EP1085021A4 (en)	1998-05-21	2003-01-08	Shionogi & Co	DERIVATIVES OF PYRROLO 1,2-B] PYRIDAZINE, WITH INHIBITOR EFFECT ON SPLA 2?
WO2000021563A1 (fr)	1998-10-14	2000-04-20	Shionogi & Co., Ltd.	Moyens de traitement et de prevention contre les troubles ischemiques dus a la repercussion
US6461538B2 (en) *	1999-12-16	2002-10-08	Fuji Photo Film Co., Ltd.	Production process for indolizine compounds and their use in organic light-emitting devices
US20040116462A1 (en) *	2002-12-12	2004-06-17	Mitsunori Ono	Indolizine compounds
DE60205265T2 (de) *	2001-09-13	2006-03-30	Synta Pharmaceuticals Corporation, Lexington	1-glyoxylamidindolizine zur behandlung von krebs

2002
- 2002-09-13 DE DE60205265T patent/DE60205265T2/de not_active Expired - Fee Related
- 2002-09-13 AT AT02798231T patent/ATE300542T1/de not_active IP Right Cessation
- 2002-09-13 US US10/244,088 patent/US6861436B2/en not_active Expired - Fee Related
- 2002-09-13 AU AU2002333626A patent/AU2002333626B2/en not_active Ceased
- 2002-09-13 EP EP02798231A patent/EP1432709B8/en not_active Expired - Lifetime
- 2002-09-13 WO PCT/US2002/029154 patent/WO2003022846A1/en active IP Right Grant
- 2002-09-13 KR KR10-2004-7003754A patent/KR20040053125A/ko not_active Application Discontinuation
- 2002-09-13 BR BR0212794-6A patent/BR0212794A/pt not_active IP Right Cessation
- 2002-09-13 IL IL16081002A patent/IL160810A0/xx unknown
- 2002-09-13 CA CA002459886A patent/CA2459886A1/en not_active Abandoned
- 2002-09-13 CN CNA028202848A patent/CN1568324A/zh active Pending
- 2002-09-13 PT PT02798231T patent/PT1432709E/pt unknown
- 2002-09-13 ES ES02798231T patent/ES2245747T3/es not_active Expired - Lifetime
- 2002-09-13 MX MXPA04002323A patent/MXPA04002323A/es unknown
- 2002-09-13 JP JP2003526921A patent/JP2005504795A/ja active Pending
- 2002-09-13 NZ NZ531700A patent/NZ531700A/en unknown
2004
- 2004-03-11 NO NO20041035A patent/NO20041035L/no not_active Application Discontinuation
- 2004-03-11 ZA ZA200401996A patent/ZA200401996B/xx unknown
- 2004-03-11 IS IS7176A patent/IS7176A/is unknown
- 2004-05-20 US US10/849,978 patent/US20040214850A1/en not_active Abandoned
- 2004-08-13 HK HK04106091A patent/HK1063322A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
ATE300542T1 (de)	2005-08-15
KR20040053125A (ko)	2004-06-23
US20040214850A1 (en)	2004-10-28
EP1432709A1 (en)	2004-06-30
CA2459886A1 (en)	2003-03-20
EP1432709B8 (en)	2005-11-02
EP1432709B1 (en)	2005-07-27
AU2002333626B2 (en)	2006-06-29
WO2003022846A1 (en)	2003-03-20
NO20041035L (no)	2004-04-30
MXPA04002323A (es)	2005-04-08
ZA200401996B (en)	2005-05-31
US20030153759A1 (en)	2003-08-14
DE60205265T2 (de)	2006-03-30
ES2245747T3 (es)	2006-01-16
CN1568324A (zh)	2005-01-19
NZ531700A (en)	2006-10-27
BR0212794A (pt)	2004-10-05
IS7176A (is)	2004-03-11
PT1432709E (pt)	2005-10-31
HK1063322A1 (en)	2004-12-24
JP2005504795A (ja)	2005-02-17
DE60205265D1 (de)	2005-09-01
US6861436B2 (en)	2005-03-01

Similar Documents

Publication	Publication Date	Title
EP1432709B8 (en)	2005-11-02	1-glyoxylamide indolizines for treating cancer
NO20050418L (no)	2005-04-28	Kondenserte pyridiner og pyrimidiner med TIE2(TEK) aktivitet
AU2003257302A1 (en)	2004-03-03	Phosphonium and imidazolium salts and methods of their preparation
ES2194584A1 (es)	2003-11-16	Monoacilalquilfosfinas organometalicas.
MX2007012951A (es)	2008-01-11	Procedimiento para preparar derivados de pirido[2,3-d] pirimidin-7-ona y 3,4-dihidropirimidino[4,5-d]pirimidin-2(1h)-ona.
CO5690577A2 (es)	2006-10-31	Derivados de imidazoquinolina como ligandos receptores de adenosina a3
NO20052781L (no)	2005-07-07	Forbindelser og prosesser
WO2008136444A1 (ja)	2008-11-13	縮合複素環誘導体
YU160189A (sh)	1992-09-07	Anelirani derivati tetrahidropiridinocetne kisline in postopki za njihovo pripravo
CA2461060A1 (en)	2003-03-27	Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof
ES2130438T3 (es)	1999-07-01	Derivados de imidazo(1,2-a)pirazin-4-ona, su preparacion y los medicamentos que les contienen.
DK471586D0 (da)	1986-10-02	3-vinyl- og 3-ethynyl-beta-carbolinderivater, deres fremstilling og deres anvendelse som laegemiddel
Ahn et al.	2000	Practical synthesis of (S)‐7‐(2‐isopropylamino) ethylcamptothecin hydrochloride, potent topoisomerase I inhibitor
GB0401336D0 (en)	2004-02-25	Organic compounds
DK118287D0 (da)	1987-03-06	Heteroaryloxy-beta-carbolinderivater, deres fremstilling og deres anvendelse som laegemiddel
HUP0201475A2 (hu)	2003-10-28	Heteroarilamidin-, metilamidin- és guanidinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
TW200602039A (en)	2006-01-16	1-Glyoxylamide indolizines for treating lung and ovarian cancer
DK1303512T3 (da)	2005-10-10	Fremgangsmåde til fremstilling af arylacetylaminothiazoler
DK0712395T3 (da)	2002-06-17	Fremgangsmåde til fremstilling af fluoralkenylthio-heterocykliske derivater
Schantl et al.	1998	Expedient synthesis of N-substituted 2-aminothiazoles
AR036735A1 (es)	2004-09-29	Derivados de 5-metoxi-8-aril-[1,2,4]triazolo[1,5-a]piridina
DK1101756T3 (da)	2003-07-14	Aminopyrrolinderivater, fremgangsmåder til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
EA200301079A1 (ru)	2004-02-26	Терапевтическое средство по поводу повышенной чувствительности мочевого пузыря
PE20001035A1 (es)	2000-10-18	Derivados de benzoxazina y benzotiazina como inhibidores de monoxido de nitrogeno sintasa
NO955071L (no)	1995-12-14	abeo-Ergolin-derivater som 5HT1A-ligander